Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment-Reference-Cited by-同舟云学术

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

Published:2009-06-01 Issue:9 Volume:23 Page:1109-1118
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Haubrich Richard H,Riddler Sharon A,DiRienzo A Gregory,Komarow Lauren,Powderly William G,Klingman Karin,Garren Kevin W,Butcher David L,Rooney James F,Haas David W,Mellors John W,Havlir Diane V

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference28 articles.

1. Cardiovascular risk and body-fat abnormalities in HIV-infected adults;Grinspoon;N Engl J Med,2005

2. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group;Dube;Clin Infect Dis,2000

3. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy;Wohl;Clin Infect Dis,2006

4. An objective case definition of lipodystrophy in HIV-infected adults: a case–control study;Carr;Lancet,2003

5. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.;Carr;AIDS,1998

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas;Life;2024-03-28

2. Non‐Inflammatory Disorders of Subcutaneous Fat;Rook's Textbook of Dermatology;2024-02-20

3. Dyslipidemia among adult people living with HIV on dolutegravir – based antiretroviral therapy at a private tertiary hospital in Kampala, Uganda: burden and determinants;BMC Infectious Diseases;2024-01-05

4. Weight Gain in People with HIV: The Role of Demographics, Antiretroviral Therapy, and Lifestyle Factors on Weight;AIDS Research and Human Retroviruses;2023-12-01

5. Alteration in Gut Microbiome and Intestinal Barrier Function caused by Efavirenz versus Dolutegravir Treatments in Mice;2023-11-03